Table 3

Study characteristics

Study characteristics: Ref13 Ref14 Refs 15,16 Ref17 Ref18 Ref19 Ref20 Ref21 Ref22 Ref 23
Patients
Osteoarthritisxxxxx
Rheumatoid arthritisxxxxx
Treatment
Misoprostolxxxxxxxxxx
Placeboxxxxxxxxxx
H2 receptor antagonistx
Misoprostol/diclofenacx
Study design
Meta-analysisxxx
RCTxxxxxxx
Cohort studyx
Population surveyx
Selected literaturexx
Costs
3-150 Direct costs:
 Admission to hospitalxxxxxxxxxx
 Ambulatory carexxxxxxxxx
 Drug treatment (prophylaxis)xxxxxxxxxx
 Treatment of adverse eventsxx
 Doctor's visitxxxx
3-150 Indirect costs x
Primary outcome
Cost/lives savedxx
Cost/adverse events avertedxx
Cost/QALY3-151 x
Cost/patientxxxx
Cost onlyx
Misoprostol compared with placebo:
Cost effectivexa3-150 xx
Conditionally cost effectivexxxx
Cost onlyx
Costlyx
  • 3-150 Arthrotec.

  • 3-151 QALY = quality adjusted life year.